Grace Therapeutics, Inc.

GRCE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
D Aug 11, 2026
SCHEDULE 13G Aug 7, 2026
8-K Aug 6, 2026 8-K
DEFA14A Jul 28, 2026 DEFA14A
DEF 14A Jul 28, 2026 DEF 14A
8-K Jul 28, 2026 8-K
8-K Jun 18, 2026 8-K
8-K Jun 18, 2026 8-K
10-K Jun 18, 2026 10-K
8-K Jun 5, 2026 8-K
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A Apr 27, 2026
8-K Apr 27, 2026 8-K
8-K Apr 23, 2026 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 13, 2026
8-K Feb 12, 2026 8-K
10-Q Feb 12, 2026 10-Q
SCHEDULE 13G/A Jan 28, 2026
8-K Jan 12, 2026 8-K
4 Jan 12, 2026 FORM 4
4 Jan 12, 2026 FORM 4
4 Jan 12, 2026 FORM 4
4 Jan 12, 2026 FORM 4
10-Q/A Nov 17, 2025 10Q/A
← Newer Page 2 of 24 · 592 filings Older →